Buy Fate Therapeutics Stock | FATE Stock Price & Latest News | Public
FATE

Fate Therapeutics

$0.00 (0.00%)Today

    About FATE

    Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products include immuno-ocology candidates and immuno-regulation candidates. The company was founded by Philip Beachy, Sheng Ding, R...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.23
    -0.45
    -0.68
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.38

    Actual EPS
    Q4 2020

    Stats

    Market Cap$5,25B
    Volume34,22k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$60.68
    1 Year Low$13.26
    Open$59.84
    High$61.34
    Low$58.80

    Buy any stock with any amount of money.

    Download the App
    Download the app